Investigating and Resolving Cardiotoxicity Induced by COVID‐19 Treatments using Human Pluripotent Stem Cell‐Derived Cardiomyocytes and Engineered Heart Tissues

Coronavirus disease 2019 continues to spread worldwide. Given the urgent need for effective treatments, many clinical trials are ongoing through repurposing approved drugs. However, clinical data regarding the cardiotoxicity of these drugs are limited. Human pluripotent stem cell‐derived cardiomyocy...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, He, Liu, Ge, Gong, Jixing, Zhang, Ying, Gu, Shanshan, Wan, Zhongjun, Yang, Pengcheng, Nie, Yage, Wang, Yinghan, Huang, Zhan‐peng, Luo, Guanzheng, Chen, Zhongyan, Zhang, Donghui, Cao, Nan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539280/
https://www.ncbi.nlm.nih.gov/pubmed/36055796
http://dx.doi.org/10.1002/advs.202203388

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539280/
https://www.ncbi.nlm.nih.gov/pubmed/36055796
http://dx.doi.org/10.1002/advs.202203388

Ejemplares similares